Dr. Kenneth Leung, M.D

NPI: 1518306471
Total Payments
$10,085
2024 Payments
$1,101
Companies
36
Transactions
415
Medicare Patients
4,254
Medicare Billing
$369,272

Payment Breakdown by Category

Food & Beverage$10,008 (99.2%)
Education$76.99 (0.8%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $10,008 414 99.2%
Education $76.99 1 0.8%

Top Paying Companies

Company Total Records Latest Year
GlaxoSmithKline, LLC. $3,129 149 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $1,264 50 $0 (2023)
Actelion Pharmaceuticals US, Inc. $1,078 36 $0 (2024)
United Therapeutics Corporation $596.87 14 $0 (2023)
Novartis Pharmaceuticals Corporation $502.79 24 $0 (2024)
AstraZeneca Pharmaceuticals LP $397.19 18 $0 (2024)
GENZYME CORPORATION $309.25 11 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $296.29 17 $0 (2023)
Genentech USA, Inc. $267.59 17 $0 (2023)
PORTOLA PHARMACEUTICALS, INC. $246.82 3 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,101 48 GlaxoSmithKline, LLC. ($515.19)
2023 $1,473 64 GlaxoSmithKline, LLC. ($583.04)
2022 $1,532 71 GlaxoSmithKline, LLC. ($552.33)
2021 $1,582 73 GlaxoSmithKline, LLC. ($470.10)
2020 $615.51 34 GlaxoSmithKline, LLC. ($241.13)
2019 $1,489 61 GlaxoSmithKline, LLC. ($501.54)
2018 $1,872 52 Boehringer Ingelheim Pharmaceuticals, Inc. ($673.39)
2017 $421.39 12 Actelion Pharmaceuticals US, Inc. ($106.48)

All Payment Transactions

415 individual payment records from CMS Open Payments — Page 1 of 17

Date Company Product Nature Form Amount Type
12/19/2024 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $9.65 General
Category: IMMUNOLOGY
12/12/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $22.25 General
Category: RESPIRATORY
12/05/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $19.62 General
Category: RESPIRATORY
11/21/2024 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $21.37 General
Category: IMMUNOLOGY
11/21/2024 GlaxoSmithKline, LLC. AREXVY (Drug), TRELEGY ELLIPTA Food and Beverage In-kind items and services $19.73 General
Category: RESPIRATORY
11/14/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $19.07 General
Category: RESPIRATORY
11/06/2024 Actelion Pharmaceuticals US, Inc. UPTRAVI (Drug) Food and Beverage In-kind items and services $11.51 General
Category: Cardiology
10/24/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $16.06 General
Category: RESPIRATORY
10/16/2024 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $1.10 General
Category: IMMUNOLOGY
10/09/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $14.69 General
Category: RESPIRATORY
09/25/2024 GlaxoSmithKline, LLC. AREXVY (Drug), TRELEGY ELLIPTA Food and Beverage In-kind items and services $20.45 General
Category: RESPIRATORY
09/25/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $0.62 General
Category: RESPIRATORY
09/24/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $34.79 General
Category: Immunology
09/12/2024 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $5.76 General
Category: IMMUNOLOGY
09/11/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $9.99 General
Category: RESPIRATORY
08/29/2024 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $8.53 General
Category: IMMUNOLOGY
08/28/2024 GlaxoSmithKline, LLC. AREXVY (Drug), TRELEGY ELLIPTA Food and Beverage In-kind items and services $17.57 General
Category: RESPIRATORY
08/14/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $15.97 General
Category: RESPIRATORY
08/06/2024 Actelion Pharmaceuticals US, Inc. UPTRAVI (Drug), OPSUMIT Food and Beverage In-kind items and services $150.00 General
Category: Cardiology
08/01/2024 GlaxoSmithKline, LLC. AREXVY (Drug), TRELEGY ELLIPTA Food and Beverage In-kind items and services $22.73 General
Category: RESPIRATORY
07/29/2024 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $2.28 General
Category: IMMUNOLOGY
07/25/2024 Merck Sharp & Dohme LLC WINREVAIR (Biological) Food and Beverage In-kind items and services $63.74 General
Category: CARDIOVASCULAR
06/26/2024 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $2.75 General
Category: IMMUNOLOGY
06/20/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $10.44 General
Category: RESPIRATORY
06/18/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $36.07 General
Category: Immunology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 14 768 942 $153,118 $54,800
2022 14 1,054 1,315 $197,016 $74,780
2021 16 1,345 1,756 $308,307 $113,309
2020 15 1,087 1,548 $344,108 $126,383
Total Patients
4,254
Total Services
5,561
Medicare Billing
$369,272
Procedure Codes
59

All Medicare Procedures & Services

59 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99291 Critical care, first 30-74 minutes Facility 2023 48 89 $45,615 $14,446 31.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 76 116 $17,278 $7,938 45.9%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 50 85 $19,660 $7,552 38.4%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 82 118 $18,276 $7,012 38.4%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 47 48 $18,745 $6,177 33.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 59 75 $6,338 $3,174 50.1%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2023 33 33 $8,739 $3,058 35.0%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 18 18 $4,950 $1,577 31.9%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 13 13 $2,775 $1,301 46.9%
94726 Test to determine lung volumes using sensors Facility 2023 94 94 $3,388 $746.04 22.0%
94729 Test to examine how well the lungs exchange gases Facility 2023 105 106 $2,827 $605.65 21.4%
94060 Test to measure expiratory airflow and volume changes before and after medication administration Facility 2023 74 74 $2,538 $500.12 19.7%
99212 Established patient office or other outpatient visit, 10-19 minutes Facility 2023 17 17 $701.00 $431.09 61.5%
94010 Test to measure expiratory airflow and volume Facility 2023 52 56 $1,288 $283.36 22.0%
99291 Critical care, first 30-74 minutes Facility 2022 52 102 $52,122 $17,037 32.7%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 90 180 $34,740 $14,067 40.5%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 136 203 $27,202 $10,894 40.0%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 65 69 $25,944 $10,235 39.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 84 127 $19,568 $9,160 46.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 72 79 $7,426 $3,982 53.6%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2022 35 35 $9,155 $3,554 38.8%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 19 19 $4,864 $1,850 38.0%
94726 Test to determine lung volumes using sensors Facility 2022 142 142 $5,254 $1,278 24.3%
94729 Test to examine how well the lungs exchange gases Facility 2022 156 156 $4,212 $1,039 24.7%
94060 Test to measure expiratory airflow and volume changes before and after medication administration Facility 2022 95 95 $3,515 $705.19 20.1%

About Dr. Kenneth Leung, M.D

Dr. Kenneth Leung, M.D is a Internal Medicine healthcare provider based in Ashland, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2013. The National Provider Identifier (NPI) number assigned to this provider is 1518306471.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Leung, M.D has received a total of $10,085 in payments from pharmaceutical and medical device companies, with $1,101 received in 2024. These payments were reported across 415 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($10,008).

As a Medicare-enrolled provider, Leung has provided services to 4,254 Medicare beneficiaries, totaling 5,561 services with total Medicare billing of $369,272. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Pulmonary Disease, Pulmonary Disease
  • Location Ashland, KY
  • Active Since 06/24/2013
  • Last Updated 11/30/2021
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1518306471

Products in Payments

  • TRELEGY ELLIPTA (Drug) $1,866
  • NUCALA (Biological) $1,040
  • UPTRAVI (Drug) $843.99
  • SPIRIVA RESPIMAT (Drug) $603.89
  • TYVASO (Drug) $384.67
  • XOLAIR (Drug) $269.42
  • Xolair (Biological) $236.72
  • XOLAIR (Biological) $233.37
  • ACTHAR (Biological) $228.49
  • GLASSIA (Biological) $223.81
  • OFEV (Drug) $220.09
  • DUPIXENT (Biological) $218.84
  • TEZSPIRE (Biological) $179.20
  • CardioMEMS HF System (Device) $170.44
  • TUDORZA PRESSAIR (Drug) $157.82
  • XARELTO (Drug) $146.55
  • BEVYXXA (Drug) $136.75
  • DUPIXENT (Drug) $132.47
  • LONHALA MAGNAIR (Drug) $131.75
  • FASENRA (Biological) $120.10

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Ashland